Quick Menu

Upcoming Journals
  • No Upcoming Journals

International Journal of Medical and Pharmaceutical Case Reports

International Journal of Medical and Pharmaceutical Case Reports, 2394-109X,Vol.: 8, Issue.: 2

 

Case Study

 

Linezolid Therapy – A Cause of Bone Marrow Suppression in a Child

 

 

Vanny Arora1, Anju Aggarwal1*, Sonali Verma1 and Manish Narang1

1Department of Pediatrics, University College of Medical Sciences and Guru Tegh Bahadur Hospital, New Delhi -110095, India.

 

Abstracts

 

Aim: To highlight the importance of monitoring rare side effects of commonly used drugs. Linezolid induced bone marrow (BM) suppression is rare side effect of therapy and rarely reported in the pediatrics age group.

Case Description: A seven year old patient, with persistent discharge from skull suture site following surgery, developed bone marrow suppression 28 days following the start of treatment with Linezolid. BM suppression was fully reversible following discontinuation of Linezolid and all cell lines returned to near baseline 2 weeks after the discontinuation of the drug.

Discussion: The potent activity of Linezolid against Gram-positive bacteria, and its excellent bioavailability after oral dosing, have made it an important addition to the antibiotic armamentarium. Linezolid is relatively a safer drug and BM suppression is a rarely reported side effect, which is particularly observed when the drug is administered for more than 14 days. 

Conclusion: Case highlights the importance of weekly monitoring of complete blood counts in patients who receive Linezolid for more than 14 days.

 

Keywords :

Linezolid; bone marrow suppression; pediatric population.

 

Full Article - PDF    Page 1-4    Article Metrics

 

DOI : 10.9734/IJMPCR/2016/30081

Review History    Comments

Search this site

Advanced Search

Announcement & News

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

Index Copernicus Value of British Journal of Medicine and Medical Research

  We are delighted to inform that Index Copernicus (a leading indexing organization ...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Publication and site statistics (up to Sept, 2015)

  Number of submission: 22181 (Total up to Sept, 2015) Number of published paper: 10949&n...

Index Medicus selected 15 SDI journals

We are delighted to inform that Index Medicus (IMSEAR) has selected following 15 SDI journals for in...

SCIENCEDOMAIN international received 5844 submissions in 2013

SCIENCEDOMAIN international is pleased to announce that it has received 5844 submissions in 2013, ac...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

Polish Ministry of Science and Higher Education included 18 SDI journals in its official report of 2013

SDI is pleased to announce that Polish Ministry of Science and Higher Education included 18 SDI jour...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...



SCIENCEDOMAIN Awards

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2017, SCIENCEDOMAIN international. All rights reserved.